Ticker > Company >

Krishna Inst.Medi share price

Krishna Institute of Medical Sciences Ltd

NSE: KIMS BSE: 543308 SECTOR: Hospital & Healthcare Services  1.33 L   209   53

736.00
-2.75 (-0.37%)
BSE: 23 Sep 04:01 PM

Price Summary

Today's High

₹ 742.1

Today's Low

₹ 731.9

52 Week High

₹ 798

52 Week Low

₹ 474.55

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

29450.23 Cr.

Enterprise Value

30128.73 Cr.

No. of Shares

40.01 Cr.

P/E

97.84

P/B

13.23

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  55.65

CASH

29.5 Cr.

DEBT

708 Cr.

Promoter Holding

34.11 %

EPS (TTM)

₹  7.52

Sales Growth

13.26%

ROE

15.02 %

ROCE

16.99%

Profit Growth

28.73 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Krishna Institute of Medical Sciences Ltd

KIMS Hospitals KIMS Cuddles

Index Presence

The company is present in 19Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.26%
3 Year6.58%
5 Year11.87%

Profit Growth

1 Year28.73%
3 Year2.86%
5 Year20.12%

ROE%

1 Year15.02%
3 Year15.09%
5 Year18.85%

ROCE %

1 Year16.99%
3 Year18.86%
5 Year23.48%

Debt/Equity

0.3266

Price to Cash Flow

100.31

Interest Cover Ratio

15.6051

CFO/PAT (5 Yr. Avg.)

1.11534103784274

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 34.11 0.00
Mar 2025 38.82 12.03
Dec 2024 38.82 12.13
Sep 2024 38.82 15.35
Jun 2024 38.82 15.78
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has a healthy Interest coverage ratio of 15.6051.
  • The Company has been maintaining an effective average operating margins of 32.03436% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -63.9196 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.11534103784274.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.94847842868743.

 Limitations

  • The company has shown a poor profit growth of 2.85541830638993% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.5759442119699% for the Past 3 years.
  • The company is trading at a high PE of 97.84.
  • The company is trading at a high EV/EBITDA of 62.2623.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 327.4 363.3 347.5 345.9 373.4
Total Expenditure 233.6 252.2 244.6 237.1 275.9
Operating Profit 93.8 111.1 102.9 108.8 97.5
Other Income 5.3 6.6 20.6 24.2 12.2
Interest 3.8 4.6 6.7 8.2 12.5
Depreciation 13.7 14 14.9 15.1 17.5
Exceptional Items 0 0 0 10.8 0
Profit Before Tax 81.6 99.1 101.9 120.5 79.7
Tax 20.9 26.9 25.4 27 20.9
Profit After Tax 60.7 72.2 76.5 93.5 58.8
Adjusted EPS (Rs) 1.52 1.8 1.91 2.34 1.47

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 932.69 1143.38 1132.02 1222.1 1384.1
Total Expenditure 625.11 745.5 768.88 856.6 963.2
Operating Profit 307.58 397.88 363.14 365.5 420.9
Other Income 9.62 26.96 24.28 18.2 56.7
Interest 18.33 8.91 4.8 7.4 27.6
Depreciation 44.6 44.92 45.3 58.1 57.7
Exceptional Items 0 0 0 0 10.8
Profit Before Tax 254.26 371 337.33 318.2 403.1
Tax 65.61 92.64 84.84 82.9 100.2
Net Profit 188.65 278.37 252.49 235.3 302.9
Adjusted EPS (Rs.) 4.86 6.96 6.31 5.88 7.57

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 77.59 80.03 80.03 80 80
Total Reserves 829.73 1297.52 1550.83 1786.4 2088
Borrowings 67.78 4.17 0 257.2 577.1
Other N/C liabilities 48.53 52.81 61.53 63.7 85.3
Current liabilities 190.09 134.25 119.68 209.3 358.7
Total Liabilities 1213.73 1568.78 1812.07 2396.6 3189.1
Assets
Net Block 582.39 591.97 612.28 673.9 773.3
Capital WIP 7.6 13.19 15.97 292 530.3
Intangible WIP 0 0 0 0 0
Investments 213.22 542.01 784.87 1000.7 1225.8
Loans & Advances 38.94 88.18 158.74 126.9 336.2
Other N/C Assets 4.35 2.16 3.17 1.9 24.1
Current Assets 367.23 331.28 237.04 301.2 299.4
Total Assets 1213.73 1568.78 1812.07 2396.6 3189.1
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 254.26 371 337.33 318.2 403.1
Adjustment 54.74 26.5 25.4 47.6 23.5
Changes in Assets & Liabilities 25.07 -16.85 -17.17 -18.1 -43.2
Tax Paid -42.72 -96.28 -74.52 -85.3 -89.8
Operating Cash Flow 291.35 284.37 271.05 262.4 293.6
Investing Cash Flow -316.6 -375.08 -237.67 -568.6 -626.6
Financing Cash Flow 25.37 75.98 -15.14 288.6 338.6
Net Cash Flow 0.12 -14.73 18.24 -17.6 5.6

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 38.82 38.82 38.82 38.82 34.11
abhinay bollineni 0.06 0.06 0.06 0.06 0.06
adwik bollineni 0.01 0.01 0.01 0.01 0.01
bhaskara rao bollineni 26.27 26.27 26.27 26.27 26.27
bluebridge capital privat... - - 6.05 6.05 6.05
rajyasri bollineni 1.72 1.72 1.72 1.72 1.72
sweata raavi 0.01 0.01 0.01 0.01 0.01
b krishnaiah 0.22 0.22 0.22 0.22 -
bollineni aishwarya 0.18 0.18 0.18 0.18 -
bollineni seenaiah naidu... 4.27 4.27 4.27 4.27 -
sujatha bollineni 0.04 0.04 0.04 0.04 -
bollineni ramanaiah memor... 6.05 6.05 - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 61.18 61.18 61.18 61.18 65.89
amansa holdings private l... 1.99 1.93 1.93 1.93 1.93
axis mutual fund trustee ... 4.42 4.42 4.96 5.17 5.24
bollineni seenaiah naidu... - - - - 4.27
hdfc life insurance compa... 1.89 1.71 1.28 1.19 1.05
hdfc small cap fund 4.20 4.34 4.41 4.49 4.38
invesco india flexi cap f... - - - - 1.23
kotak small cap fund 1.60 2.86 2.86 3.07 3.05
lilac investments limited... - 1.96 1.96 1.96 1.96
llp 0.03 0.01 0.01 0.01 0.01
nippon life india trustee... 1.33 1.64 1.65 1.67 1.55
nomura india investment f... 1.77 1.77 1.72 1.72 1.72
sbi life insurance co. lt... 1.85 2.87 2.90 3.52 3.44
sbi small cap fund 7.23 7.21 7.10 6.31 6.02
tata aia life insurance c... 1.64 1.46 1.43 1.40 1.32
venkata krishna kumar kod... 1.26 1.26 1.26 1.26 1.26
icici prudential elss tax... - 1.41 - - -
emerald investments limit... 1.96 - - - -
icici prudential long ter... 1.80 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2016
Annual Report 2015

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research Way2wealth
Research Geojit
Research Way 2 Wealth
Research Edelweiss
Research NuvamaWealth
Research Nuvama Wealth
Research Edelweiss
Research HDFC Securities
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q3FY23
Concall Q2FY24
Concall Q1FY25
Concall Q1FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY22
Presentation Q3FY24
Presentation Q3FY22
Presentation Q2FY24
Presentation Q2FY22
Presentation Q1FY25
Presentation Q1FY24

Company News

Krishna Institute of Medical Sciences informs about updates 15 Sep, 4:57 PM Krishna Institute’s arm starts operations at new hospital in Bengaluru 15 Sep, 2:51 PM Krishna Inst.Medi - Quaterly Results 6 Aug, 2:52 PM Krishna Inst.Medi - Quaterly Results 6 Aug, 2:52 PM Krishna Inst.Medi - Quaterly Results 6 Aug, 2:52 PM Krishna Institute of Medical Sciences informs about analyst meet 21 Jun, 4:14 PM Krishna Institute of Medical Sciences informs about analyst meet 21 Jun, 4:14 PM Krishna Institute of Medical Sciences informs about analyst meet 18 Jun, 6:32 PM Krishna Inst.Medi - Quaterly Results 12 May, 7:23 PM Krishna Inst.Medi - Quaterly Results 12 May, 7:23 PM Krishna Institute of Medical Sciences informs about analyst meet 5 Mar, 3:13 PM Krishna Institute of Medical Sciences informs about disclosure 20 Feb, 5:27 PM Krishna Institute enters into strategic partnership with UAIMS Hospital, Sangli 18 Feb, 9:46 AM Krishna Inst.Medi - Quaterly Results 6 Feb, 5:02 PM Krishna Inst.Medi - Quaterly Results 6 Feb, 5:02 PM Krishna Inst.Medi - Quaterly Results 6 Feb, 5:02 PM Krishna Institute’s arm inks pact with Valiyath Institute of Medical Sciences 28 Jan, 6:25 PM Krishna Institute of Medical Sciences informs about appointment of additional director 4 Jan, 3:05 PM Krishna Institute of Medical Sciences informs about appointment of CS cum CO 4 Jan, 3:04 PM Krishna Institute of Medical Sciences submits analyst meet intimation 10 Dec, 1:19 PM Krishna Institute of Medical Sciences submits analyst meet intimation 7 Dec, 4:56 PM Krishna Institute of Medical Sciences informs about analyst meet 6 Dec, 2:34 PM Krishna Institute of Medical acquires additional 3% stake in M/s. Arunodaya Hospitals 6 Dec, 10:10 AM Krishna Institute of Medical Sciences informs about investor meet 29 Nov, 4:58 PM Krishna Institute of Medical Sciences informs about investor meet 29 Nov, 4:55 PM Krishna Institute of Medical Sciences inks pact with Insignia Healthcare 11 Nov, 10:12 AM Krishna Inst.Medi - Quaterly Results 9 Nov, 4:01 PM Krishna Inst.Medi - Quaterly Results 9 Nov, 4:01 PM Krishna Inst.Medi - Quaterly Results 9 Nov, 4:01 PM Krishna Institute of Medical to develop new medical facilities in Kerala 6 Nov, 6:01 PM Krishna Institute of Medical makes further investment in M/s. Sarvejana Healthcare 31 Oct, 10:11 AM Krishna Institute of Medical acquires additional stake in Sarvejana Healthcare 22 Oct, 3:57 PM Krishna Institute inks MoU with Wipro GE Healthcare 18 Oct, 4:42 PM Krishna Institute of Medical acquires 100% equity stake in QNRI 30 Aug, 5:53 PM Krishna Institute of Medical Sciences informs about press release 8 Aug, 3:02 PM Krishna Inst.Medi - Quaterly Results 7 Aug, 5:03 PM Krishna Inst.Medi - Quaterly Results 7 Aug, 5:03 PM Krishna Inst.Medi - Quaterly Results 7 Aug, 5:03 PM Krishna Institute of Medical Sciences to acquire 200-bed multi-specialty hospital in Vizag 9 Jul, 5:53 PM Krishna Institute of Medical Sciences informs about closure of trading window 24 Jun, 12:53 PM Krishna Institute of Medical Sciences executes agreement to invest in M/s Meda Institute of Podiatry 11 Jun, 3:50 PM Krishna Institute of Medical Sciences informs about analyst meet 3 Jun, 5:29 PM Krishna Institute of Medical Sciences informs about analyst meet 3 Jun, 5:28 PM Krishna Institute of Medical Sciences submits analyst meet intimation 3 Jun, 5:23 PM Krishna Institute of Medical enters into lease agreement to set up Super Specialty Hospital in Bengaluru 31 May, 9:51 AM Krishna Institute of Medical Sciences executes agreement to invest in M/s. KIMS Hospital Bengaluru 21 May, 10:02 AM Krishna Institute of Medical Sciences informs about newspaper publication 17 May, 12:22 PM Krishna Inst.Medi - Quaterly Results 16 May, 5:55 PM Krishna Inst.Medi - Quaterly Results 16 May, 5:55 PM Krishna Inst.Medi - Quaterly Results 16 May, 5:55 PM

Krishna Inst.Medi Stock Price Analysis and Quick Research Report. Is Krishna Inst.Medi an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Krishna Inst.Medi. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Krishna Inst.Medi has a PE ratio of 97.894289056684 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Krishna Inst.Medi has ROA of 10.8456% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Krishna Inst.Medi has a Current ratio of 0.8347.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Krishna Inst.Medi has a ROE of 15.0159%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Krishna Inst.Medi has a Debt to Equity ratio of 0.3266 which means that the company has low proportion of debt in its capital.

  • Sales growth: Krishna Inst.Medi has reported revenue growth of 13.2559% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Krishna Inst.Medi for the current financial year is 30.4096524817571%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Krishna Inst.Medi is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Krishna Inst.Medi is Rs 7.5224. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Krishna Inst.Medi in Ticker for free. Also, one can get the intrinsic value of Krishna Inst.Medi by using Valuation Calculators, which are available with a Finology ONE subscription. 

Krishna Inst.Medi FAQs

Q1. What is Krishna Inst.Medi share price today?
Ans: The current share price of Krishna Inst.Medi is Rs 736.4.

Q2. What is the market capitalisation of Krishna Inst.Medi?
Ans: Krishna Inst.Medi has a market capitalisation of Rs 29466.2311734 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Krishna Inst.Medi?
Ans: The PE ratio of Krishna Inst.Medi is 97.894289056684 and the P/B ratio of Krishna Inst.Medi is 13.2323715126663, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Krishna Inst.Medi share?
Ans: The 52-week high share price of Krishna Inst.Medi is Rs 798.4, and the 52-week low share price of Krishna Inst.Medi is Rs 474.05.

Q5. Does Krishna Inst.Medi pay dividends?
Ans: Currently, Krishna Inst.Medi does not pay dividends. Dividend yield of Krishna Inst.Medi is around 0%.

Q6. What are the face value and book value of Krishna Inst.Medi shares?
Ans: The face value of Krishna Inst.Medi shares is Rs 2, while the book value per share of Krishna Inst.Medi is around Rs 55.6514. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Krishna Inst.Medi?
Ans: Krishna Inst.Medi has a total debt of Rs 708 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Krishna Inst.Medi?
Ans: The ROE of Krishna Inst.Medi is 15.0159% and ROCE of Krishna Inst.Medi is 16.9945%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Krishna Inst.Medi a good buy for the long term?
Ans: The Krishna Inst.Medi long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Krishna Inst.Medi undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Krishna Inst.Medi appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Krishna Inst.Medi’s financials?
Ans: You can review Krishna Inst.Medi’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Krishna Inst.Medi

Krishna Institute of Medical Sciences Ltd Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis 
 

Welcome to the stock analysis page of Krishna Institute of Medical Sciences Ltd. In this section, we will provide you with valuable insights into the company's performance and financials. Whether you are a seasoned investor or a beginner looking to invest in the long term, this page will serve as a comprehensive guide to understanding the stock's various aspects.

Krishna Institute of Medical Sciences Ltd Share Price

Gain an understanding of Krishna Institute of Medical Sciences Ltd share price trends and fluctuations over time. Our pre-built screening tools allow you to track the company's stock performance in real-time, enabling you to make well-informed investment decisions.

Krishna Institute of Medical Sciences Ltd Balance Sheet

Krishna Institute of Medical Sciences Ltd's balance sheet provides a snapshot of the company's financial position. With ticker premium features, you can utilize tools such as the DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis to calculate the company's fair value and evaluate its financial health.

Krishna Institute of Medical Sciences Ltd Annual Report

Access the downloadable annual reports of Krishna Institute of Medical Sciences Ltd on Ticker. The annual report provides a detailed overview of the company's business operations, financial statements, and management discussions. This valuable resource will help you gain insights into the company's performance and strategy.

Krishna Institute of Medical Sciences Ltd Dividend

Stay updated on the dividends distributed by Krishna Institute of Medical Sciences Ltd to its shareholders. Dividends are an essential aspect for long-term stock investors, and ticker platform ensures that you have the latest information regarding dividend payments and dividend yield.

Krishna Institute of Medical Sciences Ltd Quarterly Result

Track Krishna Institute of Medical Sciences Ltd quarterly results and monitor its financial performance on a regular basis. Ticker provides instant access to the company's quarterly reports, allowing you to stay informed about revenue, expenses, and other important financial metrics.

Krishna Institute of Medical Sciences Ltd Stock Price

Stay informed about Krishna Institute of Medical Sciences Ltd stock price movements through our comprehensive stock price chart. Our user-friendly interface displays the historical stock prices, giving you the ability to analyze trends and patterns in the stock's performance.

Krishna Institute of Medical Sciences Ltd News

Access the latest news and updates about Krishna Institute of Medical Sciences Ltd. Our news section provides relevant information regarding the company's operations, expansions, partnerships, and other market developments. Stay informed to make informed investment decisions.

Krishna Institute of Medical Sciences Ltd Concall Transcripts

Get access to the conference call transcripts of Krishna Institute of Medical Sciences Ltd. These transcripts provide insights into the company's management commentary, financial performance discussions, and future strategies. Utilize this information to understand the company's vision and direction.

Krishna Institute of Medical Sciences Ltd Investor Presentations

Stay updated on Krishna Institute of Medical Sciences Ltd investor presentations. These presentations provide an in-depth analysis of the company's performance, growth prospects, and market outlook. Ticker offers a comprehensive collection of investor presentations for your reference.

Krishna Institute of Medical Sciences Ltd Promoters

Learn about the promoters of Krishna Institute of Medical Sciences Ltd. Ticker platform provides detailed information about individuals or entities who have founded and currently promote the company. Understanding the promoters is crucial to evaluating their influence and long-term commitment to the company.

Krishna Institute of Medical Sciences Ltd Shareholders

Identify the major shareholders of Krishna Institute of Medical Sciences Ltd. Ticker provides a comprehensive list of significant shareholders, including institutions and individuals. This information can help you gauge investor sentiment and understand the company's ownership structure.

Krishna Institute of Medical Sciences Ltd ROCE

Return on Capital Employed (ROCE) for Krishna Institute of Medical Sciences Ltd is a critical financial metric used to evaluate the company's efficiency in generating profits from its capital investments. By examining ROCE, investors can gain valuable insights into how effectively the company is utilizing its capital to create shareholder value. The ROCE data for Krishna Institute of Medical Sciences Ltd can be accessed in the financials table or the dedicated ratio section on this page.

Krishna Institute of Medical Sciences Ltd EBITDA

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) serves as an important indicator of Krishna Institute of Medical Sciences Ltd's operational performance and profitability, excluding non-operating expenses. Analyzing EBITDA enables investors to assess the company's core operational earnings. You can find the EBITDA data for Krishna Institute of Medical Sciences Ltd in the financials table or the ratio section provided on this page.

Krishna Institute of Medical Sciences Ltd DPS

Dividends Per Share (DPS) represents the portion of Krishna Institute of Medical Sciences Ltd's profits distributed to shareholders per outstanding share. This metric holds significance for investors seeking regular dividend income. The Krishna Institute of Medical Sciences Ltd's DPS data can be found in the financials table or the ratio section on this page.

Krishna Institute of Medical Sciences Ltd EPS

Earnings Per Share (EPS) outlines the portion of Krishna Institute of Medical Sciences Ltd's profit allocated to each outstanding share of its common stock. Analyzing EPS provides insights into the company's profitability on a per-share basis. Refer to the financials table or the dedicated ratio section above for Krishna Institute of Medical Sciences Ltd's EPS data.  

Krishna Institute of Medical Sciences Equity and Reserves Growth

The Krishna Institute of Medical Sciences has shown notable growth in equity, maintaining its share capital at Rs 80.03 Cr. from March 2022 to March 2024. Furthermore, its total reserves have seen a remarkable increase from Rs 549.64 Cr. in March 2020 to Rs 1,786.42 Cr. by March 2024, showcasing strong financial health and profit retention capabilities.

Krishna Institute of Medical Sciences Borrowing and Liabilities

A significant fluctuation in borrowings has been observed, with a decrease to Rs 4.17 Cr. in March 2022, followed by a substantial rise to Rs 257.17 Cr. in March 2024. This could reflect strategic financial management or investment in growth opportunities. The company's total liabilities mirror this expansion, escalating to Rs 2,396.51 Cr. by March 2024.

Krishna Institute of Medical Sciences Asset Expansion

Krishna Institute of Medical Sciences has also effectively grown its assets, with net block increasing to Rs 673.92 Cr. and total investments reaching Rs 1,000.65 Cr. by March 2024. The significant rise in capital work in progress (WIP) to Rs 291.98 Cr. suggests substantial ongoing projects or expansion efforts.

Krishna Institute of Medical Sciences Current Assets and Investments

The current assets have seen variability, peaking at Rs 367.23 Cr. in March 2021 before stabilizing at Rs 301.17 Cr. in March 2024. This, alongside a strategic climb in investments to Rs 1,000.65 Cr., highlights a balanced approach to liquidity and long-term growth.

This analysis of the standalone balance sheet of Krishna Institute of Medical Sciences offers insights into the company's financial trajectory over the past years.

For investors or analysts exploring opportunities within the healthcare sector on platforms like NSE or BSE, these financials provide a detailed glimpse into Krishna Institute of Medical Sciences' robust and dynamic fiscal landscape.

Read More
X